
Sign up to save your podcasts
Or
Elkhan Agamirza’s domain name portfolio has been doubling every year and now stands at over 5,000 domains. He takes a detailed view into what end users want to buy, scooping up domain names that many domain investors overlook based on traditional metrics. In this show, you’ll learn how he approaches domain investing and the bottom line sell-through rate and revenue it generates.
Also: Supreme Court rules on domains and trademarks, State Farm’s generic woes, and Namecheap’s growth.
Sponsor: Donuts
Elkhan Agamirza’s domain name portfolio has been doubling every year and now stands at over 5,000 domains. He takes a detailed view into what end users want to buy, scooping up domain names that many domain investors overlook based on traditional metrics. In this show, you’ll learn how he approaches domain investing and the bottom line sell-through rate and revenue it generates.
Also: Supreme Court rules on domains and trademarks, State Farm’s generic woes, and Namecheap’s growth.
Sponsor: Donuts